Page last updated: 2024-10-23

benzbromarone and Abdominal Obesity

benzbromarone has been researched along with Abdominal Obesity in 1 studies

Benzbromarone: Uricosuric that acts by increasing uric acid clearance. It is used in the treatment of gout.
benzbromarone : 1-Benzofuran substituted at C-2 and C-3 by an ethyl group and a 3,5-dibromo-4-hydroxybenzoyl group respectively. An inhibitor of CYP2C9, it is used as an anti-gout medication.

Research Excerpts

ExcerptRelevanceReference
"Fructose-fed rats showed hyperuricemia, abdominal obesity hypertension and an activation in adipose renin-angiotensin system (RAS)."1.62Hyperuricemia Inhibition Protects SD Rats Against Fructose-Induced Obesity Hypertension Via Modulation of Inflammation and Renin-Angiotensin System in Adipose Tissue. ( Lin, X; Tang, F; Xu, J; Zhang, JX, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Zhang, JX1
Lin, X1
Xu, J1
Tang, F1

Other Studies

1 other study available for benzbromarone and Abdominal Obesity

ArticleYear
Hyperuricemia Inhibition Protects SD Rats Against Fructose-Induced Obesity Hypertension Via Modulation of Inflammation and Renin-Angiotensin System in Adipose Tissue.
    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2021, Volume: 129, Issue:4

    Topics: Adipose Tissue; Allopurinol; Animals; Benzbromarone; Diet, Carbohydrate Loading; Disease Models, Ani

2021